Sodium Citrate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 467mg
Reference Brands:
Category:
Respiratory Disorder
Injection contains the active ingredient tri sodium citrate 467mg. It is used to prevent clotting of blood in any type of intravenous catheter. Intravenous catheters are small flexible tubes that are introduced into veins for administration of medications, fluids or blood products that are unable to be taken by mouth as well as for blood sampling.
SODIUM CITRATE is available in Injection
and strengths such as 467mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, SODIUM CITRATE is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
SODIUM CITRATE can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
This injection also prevents the growth of microbes in the catheters. Citrate reactions or toxicity may occur with the return of blood containing citrate anticoagulant. The signs of citrate reactions begin with a tingling sensation around the mouth or in the extremities.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing